SONOMA PHARMACEUTICALS INC's ticker is SNOA and the CUSIP is 83558L105. A total of 28 filers reported holding SONOMA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,000 | 0.0% | 1,528 | 0.0% | 0.00% | – |
Q4 2018 | $1,000 | -50.0% | 1,528 | 0.0% | 0.00% | – |
Q3 2018 | $2,000 | -86.7% | 1,528 | -60.3% | 0.00% | – |
Q2 2018 | $15,000 | 0.0% | 3,853 | 0.0% | 0.00% | – |
Q1 2018 | $15,000 | -28.6% | 3,853 | 0.0% | 0.00% | – |
Q4 2017 | $21,000 | +950.0% | 3,853 | +1074.7% | 0.00% | – |
Q3 2017 | $2,000 | +100.0% | 328 | +92.9% | 0.00% | – |
Q2 2017 | $1,000 | 0.0% | 170 | -25.4% | 0.00% | – |
Q1 2017 | $1,000 | 0.0% | 228 | +78.1% | 0.00% | – |
Q4 2016 | $1,000 | – | 128 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BARD ASSOCIATES INC | 614,495 | $4,405,000 | 0.41% |
JW Asset Management, LLC | 100,951 | $724,000 | 0.15% |
Hartford Financial Management Inc. | 900 | $6,000 | 0.00% |
Virtu KCG Holdings LLC | 13,161 | $94,000 | 0.00% |
Acrospire Investment Management LLC | 223 | $2,000 | 0.00% |
RAYMOND JAMES & ASSOCIATES | 11,242 | $81,000 | 0.00% |
UBS Group AG | 1,094 | $8,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 1,340 | $10,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 1,014 | $7,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 15,019 | $107,000 | 0.00% |